Latanoprost/Timolol Ingen Pharma (Timolol Maleate, Latanoprost)

Latanoprost/Timolol is indicated for conditions affecting intra‑ocular pressure within the glaucoma and ocular hypertension disease family.

• Open‑angle glaucoma: lowers intra‑ocular pressure to prevent optic‑nerve damage.
• Ocular hypertension: reduces eye pressure to lower the risk of progression to glaucoma.
• Elevated intra‑ocular pressure: improves aqueous‑humor outflow to maintain normal pressure levels.

• Latanoprost, a prostaglandin F2α analogue, increases uveoscleral outflow of aqueous humor by remodeling extracellular matrix in the ciliary body. Timolol maleate, a non‑selective beta‑adrenergic antagonist, decreases aqueous‑humor production by blocking β1 and β2 receptors in the ciliary epithelium. The combined actions result in a net reduction of intra‑ocular pressure.

The most frequently reported ocular reactions are generally mild and transient.

Common Side Effects

• Eye irritation or burning sensation.
• Blurred vision shortly after instillation.
• Conjunctival hyperemia (eye redness).
• Increased eyelash length or thickness.
• Darkening of the iris color.
• Foreign‑body sensation in the eye.

Serious or Rare Side Effects

• Severe allergic reaction (e.g., angio‑edema, anaphylaxis).
• Marked bradycardia or heart block.
• Bronchospasm or severe asthma exacerbation.
• Persistent ocular pain or inflammation.
• Systemic hypotension with dizziness.
• Vision loss due to acute angle‑closure glaucoma.

Before initiating therapy, clinicians should evaluate relevant systemic and ocular factors.

• Cardiac assessment: review history of bradycardia, heart block, or heart failure.
• Respiratory evaluation: avoid in patients with severe asthma or chronic obstructive pulmonary disease.
• Ocular surgery: discontinue before intra‑ocular procedures to prevent wound‑healing complications.
• Pregnancy and lactation: use only if potential benefit justifies potential risk.
• Concomitant beta‑blockers: monitor for additive systemic beta‑blockade effects.
• Store at room temperature: keep bottle tightly closed, protect from light and freezing.

Latanoprost/Timolol may interact with other systemic or ocular agents, requiring careful management.

Major Interactions (Avoid)

• Systemic non‑selective beta‑blockers (e.g., propranolol): risk of profound bradycardia and hypotension.
• Inhaled or oral beta‑agonists for asthma: antagonism may worsen bronchospasm.
• Other topical prostaglandin analogues: additive ocular irritation.

Moderate Interactions (Monitor Closely):\n- Calcium‑channel blockers: may enhance timolol‑induced cardiac effects.

• Anticholinergic eye drops: possible reduction in ocular surface lubrication.
• Systemic antihypertensives: monitor blood pressure for additive lowering.
• NSAIDs: may interfere with prostaglandin‑mediated outflow mechanisms.